Mammoth Biosciences
mammoth.bio
Actively hiring
Rare Disease Therapeutics
Synthetic Biology
As featured in
View 1 job
Claim pageClaim
Follow
Overview
Connections
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Total raised
$20.6M
2 rounds on record
Latest round
$7.4M
Convertible Note · Aug 2018 · 8 yr ago
Team
201-500
employees, estimated range
Hiring now
1
open roles
Backers
7
8VC, NFX
The money's age
Long since its last round
98 months since the last round · hiring slowed
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 14, 2022
Recognition Mammoth Biosciences Named in BioSpace's 2023 Best Places to Work · BioSpace
May 20, 2020
Partnership Mammoth Biosciences partners with GSK to develop handheld CRISPR-based COVID-19 test · TechCrunch
Aug 10, 2018
Raised a round Convertible Note $7.4M · SEC Form D
May 15, 2018
Raised a round Venture round $13.2M · SEC Form D
Apr 26, 2018
Launched Mammoth Biosciences launches a CRISPR-powered search engine for disease detection · TechCrunch
2017
Founded
Tractionpublic signals, read monthly
Hacker News stories
1
best: 4 points
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Convertible Note | Aug 2018 | $7.4M | — | SEC Form D |
| Venture round | May 2018 | $13.2M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Mammoth Biosciences, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Trevor MartinExecutive Officer, DirectorSEC Form D
Ashley TehranchiExecutive Officer, DirectorSEC Form D
Lucas HarringtonExecutive OfficerSEC Form D
Janice ChenExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
NFX 
Foresite Capital 
Mayfield 
SV Angel 
VCSheet 
Wireframe Ventures Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Tessera Therapeutics is a biotechnology company pioneering Gene Writing technology to develop genetic medicines. It is developing in vivo…
EditCo provides CRISPR gene editing services, CRISPR products & genome engineering solutions for disease models, drug discovery and cell…
Affinia Therapeutics is expanding what's possible in adeno-associated virus (AAV) gene therapy today and bringing transformative medicines…
Reforgene is a Chinese biotechnology company developing cell and gene therapies. Its research covers ex vivo and in vivo gene editing, gene…
Myosana Therapeutics is one of the pioneering companies in non-viral gene therapy for neuromuscular and cardiac diseases.
HarborSite pioneers programmable gene insertion technology using engineered recombinase enzymes to cure genetic diseases and unlock gene…
Visa sponsorship
4
H-1B filings in 12 months
$143k
Median offered salary
1
Open roles in United States
Who they sponsor
Other biological scientists
4
In the register as Mammoth Biosciences, Inc., Brisbane, CA (+1 more)
Other sponsors in the same field
Vertex Pharmaceuticals 
Sanofi 
Genscript 
Alnylam
See 1 open role Alert me
US Department of Labor · latest filing May 11, 2026 · Visa details by country
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Show all 5 
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Mammoth Biosciences to Present at 44th Annual J.P. Morgan Healthcare Conference
Corporate presentation at 7:30 AM PST on January 15 in room Elizabethan A at the Westin St. Frances hotel, San Francisco
Read more
Report
Mammoth Biosciences to Present Preclinical Data on MB-111 at the European Society of Gene & Cell Therapy 32nd Annual Congress
BRISBANE, Calif., October 01, 2025--Oral presentation highlights safe, robust reduction in apoC-III and triglycerides by MB-111, paving the way to the clinic in 2026.
Read more
Report
Mammoth Biosciences Announces Nomination of MB-111 as First Development Candidate and Appoints Genetic Medicines Veteran Bob D. Brown to Board of Directors
MB-111 utilizes the ultracompact CasPhi gene editing system to permanently disrupt expression of the APOC3 gene in the liver.
Read more
Report
Mammoth Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
Mammoth Biosciences announces presentation at the 2025 J.P. Morgan Healthcare Conference
Read more
Report
In Vivo's 2024 Rising Leaders
The fifth annual listing of In Vivo's Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.
Read more
Report
Mammoth Biosciences
Trevor Martin describes how Mammoth is working on the evolution of CRISPR to help make it more versatile for potential use in broad in-vivo applications.
Read more
Report
Mammoth Biosciences to Present at 41st Annual J.P. Morgan Healthcare Conference
Mammoth Biosciences announces presentation at upcoming 2023 J.P. Morgan Healthcare Conference
Read more
Report
Mammoth Biosciences Named in BioSpace's 2023 Best Places to Work
Mammoth Biosciences, Inc., a biotech company harnessing next-generation CRISPR technology to cure and detect disease, today announced its recognition as a BioSpace 2023 Best Place to Work in the small employer category, a testament to the company's contin
Read more
Report
Hispanic and Latinx Heritage Month - Fireside chat with Dr. Liana F. Romero, PhD, MBA, MT(ASCP) and Maria Artunduaga, MD, MPH, MTM
As part of our Hispanic and Latinx Heritage Month celebrations, we recently sat down with two Latinx leaders in the life sciences industry. Our goal was to get their insights on the challenges and opportunities facing Latinx people and especially Latinas
Read more
Report
WAM reproductive rights awareness event
In the wake of the recent Supreme Court decision overturning Roe v. Wade, we thought that it was essential to give Mammoth team members a forum where they could safely and comfortably discuss the decision. To achieve this goal, the Womxn and Allies at Mam
Read more
Report
Show more news
Tech stack
Technologies named in job postings at Mammoth Biosciences over the last 12 months, by layer, with the share of postings for each.
Technologies in use
15
Postings analysed
1
Stack modernity
72/100
Languages
Python
SQL
Cloud & platforms
AWS
AWS Lambda
Amazon EC2
Amazon S3
Prefect
Developer tools
Benchling
Docker
LIMS
Terraform
Practices & domains
CI/CD
CRISPR
Next-Generation Sequencing
ETL/ELT
Sign in to see how your skills match this stack
Sign In
Salary insights
Compensation ranges based on this company's open jobs
Median
$178k
Typical range
$178k
Open positions
1
1
Jobs
Senior
100%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Senior | 1 | $178k | $178k |
Highest paying role
Senior Software Engineer I, Research Informatics
$178k
Normalized to USD per year
People
Trevor Martin
Executive Officer, Director
Ashley Tehranchi
Executive Officer, Director
Lucas Harrington
Executive Officer
Janice Chen
Executive Officer
Urshit Parikh
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
63/100
Growing
Open positions
1
0 opened / 0 closed in 30 days
ATS activity
Every ~4 hours
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Backend
100% ▼
Activity Timeline
New location: Brisbane
Nov 2026
Added Next-Generation Sequencing to stack
Oct 2026
Added LIMS to stack
Oct 2026
Added CRISPR to stack
Oct 2026
Added Benchling to stack
Oct 2026
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Brisbane
Brisbane
United States
HQ
1 open roles 1 posted in 90 days 100% engineering 200-500 est. staff $178k Avg Salary
hires for Backend
Jobs
$142k – $178k per year · Hybrid · Full-Time · 7+ years exp · Bachelor's Degree · Brisbane
Python
SQL
Prefect
DevOps
Terraform
CI/CD
AWS
Docker
AWS Lambda
Amazon EC2
Amazon S3
Analytics
ETL/ELT
Life Sciences
CRISPR
Next-Generation Sequencing
LIMS
Benchling
Apply